Showing results (131-140 of 151) with videos related to
Sort By:
Pageof 16
Cancer Research and Treatment|March 6, 2025
Ten-Year Follow-Up Clinical Outcomes and the Role of Adjuvant Chemotherapy in HER2-Positive Patients with Microinvasive Breast CancerYeokyeong Shin, Soo-Young Lee, Hyehyun Jeong, et al.Frontiers in Oncology|May 1, 2025
Additional prognostic value of the BCT score in ER+HER2- breast cancer patients receiving a 21-gene assay-guided adjuvant treatmentsSung Gwe Ahn, Jonghan Yu, Seung Ho Baek, et al.Clinical Immunology (Orlando, Fla.)|June 22, 2024
Expansion of tumor-infiltrating lymphocytes in non-small cell lung cancer: Clinical potential and efficacy in EGFR mutation subsetsHyun Lee, Miseon Lee, Chae Lyul Lim, et al.Cancer Research and Treatment|September 4, 2025
Long-Term Prognostic Value and Analytical Parameters of the Next-Generation Sequencing-Based Multigene Assay in Hormone Receptor-Positive, HER2-Negative Breast CancerHyunji Kim, Jiwon Koh, Hyunwoo Lee, et al.Psycho-Oncology|August 6, 2015
Patient reporting pain intensity immediately after surgery can be associated with underlying depression in women with breast cancerYoo Seok Kim, Hyuigyung Do, Jong Won Lee, et al.Breast Cancer Research : BCR|April 10, 2026
Contributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11)Seon-Hi Shin, Sung Gwe Ahn, Jai Min Ryu, et al.JAMA Network Open|May 14, 2025
Long-Term Oncologic Outcome of Breast-Conserving Treatment in Patients With Breast Cancer With BRCA VariantsJanghee Lee, Jai Min Ryu, Hong Kyu Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Development and Validation of a Next-Generation Sequencing-Based Multigene Assay to Predict the Prognosis of Estrogen Receptor-Positive, HER2-Negative Breast CancerHan-Byoel Lee, Sae Byul Lee, Minsu Kim, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2024
Impact of 18F-FES PET/CT on Clinical Decisions in the Management of Recurrent or Metastatic Breast CancerJeongryul Ryu, Jaewon Hyung, Sangwon Han, et al.Annals of Surgical Oncology|April 13, 2019
Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast CancerSung-Chan Gwark, Han Shin Lee, Youngjoo Lee, et al.Pageof 16